Membrane/Core Nanoparticles for Delivery of Therapeutic Nucleic Acid - Nanotechnology for the Delivery of Therapeutic Nucleic Acids - page 90

123. Kang, C.S., ., Suppression of EGFR expression by antisense or small

interference RNA inhibits U251 glioma cell growth

et al

in vitro and in vivo .

Cancer Gene Ther , 2006. 13 (5): pp. 530-538.

124. Vollmann, A., ., Effective silencing of EGFR with RNAi demonstrates

non-EGFR dependent proliferation of glioma cells.

et al

Int J Oncol , 2006.

(6): pp. 1531-1542.
125. Wu, X.,

28

., Combining siRNAs at two different sites in the EGFR to
suppress its expression, induce apoptosis, and enhance 5-fluorouracil
sensitivity of colon cancer cells.

et al

J Surg Res , 2007. 138 (1): pp. 56-63.

126. Zhang, X., ., Tumor growth inhibition by simultaneously blocking

epidermal growth factor receptor and cyclooxygenase-2 in a xenograft
model.

et al

Clin Cancer Res , 2005. 11 (17): pp. 6261-6269.

127. Song, E., et al ., Antibody mediated in vivo delivery of small interfering

RNAs via cell-surface receptors. Nat Biotechnol , 2005. 23 (6):

pp. 709-717.
128. Halaby, M.J., and D.Q. Yang, p53 translational control: a new facet of
p53 regulation and its implication for tumorigenesis and cancer
therapeutics.

(1-2): pp. 1-7.
129. de Nigris, F., M.L. Balestrieri, and C. Napoli, Targeting c-Myc, Ras and
IGF cascade to treat cancer and vascular disorders.

Gene , 2007. 395

Cell Cycle , 2006.

(15): pp. 1621-1628.
130. Grothey, A., Future directions in vascular endothelial growth factor-
targeted therapy for metastatic colorectal cancer.

5

Semin Oncol , 2006.

(5 Suppl. 10): pp. S41-49.
131. Li, S.D., S. Chono, and L. Huang, Efficient oncogene silencing and
metastasis inhibition via systemic delivery of siRNA.

33

Mol Ther , 2008.

(5): pp. 942-946.
132. Xu, D.H., J.Q. Gao, and W.Q. Liang, Liposome-based intracellular
kinetics of doxorubicin in K562/DOX cells.

16

Pharmazie , 2008. 63 (9):

pp. 646-649.
133. Chen, Y., ., Novel cationic lipid that delivers siRNA and enhances

therapeutic effect in lung cancer cells.

et al

Mol Pharm , 2009. 6 (3):

pp. 696-705.
134. Chen, Y., ., Multifunctional nanoparticles delivering small

interfering RNA and doxorubicin overcome drug resistance in cancer.
J Biol Chem

et al

(29): pp. 22639-22650.
135. Nakamura, Y., H. Sato, and T. Motokura, Development of multidrug
resistance

, 2010. 285

due to multiple factors including P-glycoprotein